This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Gastrointestinal Diseases  • Osteoporosis  • Malabsorption Syndromes  • Alert me on articles by topic

Improvement in Morbidity and Mortality From Osteoporosis?

Arch Intern Med. 2005;165:370-372.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Osteoporosis and celiac disease (CD) are common diseases. Some 10 million people in the United States (80% women) have osteoporosis, and another estimated 18 million have osteopenia and are at risk for osteoporosis.¹ Fourteen percent of 50-year-old white women with osteoporosis will develop a fracture over their lifetime.¹ Even patients with osteopenia, ie, bone mineral density (BMD) T score between –1.0 and –2.5, are at increased risk for fracture.² These fractures are associated with pain, disability, and up to 30% mortality at 1 year in addition to a monetary cost of an estimated $10 billion to $15 billion yearly.³

The primary reason to diagnose and treat osteoporosis is to prevent bone fractures. Low BMD is associated with increased fracture risk, and increased BMD during therapy is associated with a corresponding decrease in fracture risk.^4-5 However, BMD is only 1 factor that contributes to bone strength and fracture risk in the . . . [Full Text of this Article]

AUTHOR INFORMATION
Alan L. Buchman, MD, MSPH

RELATED ARTICLE

Increased Prevalence of Celiac Disease and Need for Routine Screening Among Patients With Osteoporosis
William F. Stenson, Rodney Newberry, Robin Lorenz, Christine Baldus, and Roberto Civitelli
Arch Intern Med. 2005;165(4):393-399.
ABSTRACT | FULL TEXT